Acceptability and perception of the herpes zoster vaccine in the 65 and over population: A French observational study

Vaccine. 2020 Aug 18;38(37):5891-5895. doi: 10.1016/j.vaccine.2020.07.004. Epub 2020 Jul 21.

Abstract

The aim of the study was to evaluate the acceptability and to describe the perception of vaccination against herpes zoster (HZ) for outpatients and hospitalized patients in Lyon, France, aged 65 years and over. An observational study was based on a questionnaire completed from a face-to-face interview from January 2018 to March 2019. Volunteer outpatients who attended private medical laboratories or who were hospitalized in the geriatric department, or who were at the ambulatory medical clinic for a consultation were asked to participate. A total of 907 individuals were interviewed, with a mean age of 75.8 years. A large majority 87.6% (795) knew about HZ and 68.9% (625) would agree to be vaccinated against HZ if they had risk factors. The participants had knowledge of HZ as a disease but vaccine awareness is still lacking among the general public.

Keywords: Acceptability; Elderly; Herpes zoster vaccine; Perception.

Publication types

  • Observational Study

MeSH terms

  • Aged
  • France
  • Herpes Zoster Vaccine*
  • Herpes Zoster* / prevention & control
  • Herpesvirus 3, Human
  • Humans
  • Perception
  • Vaccination

Substances

  • Herpes Zoster Vaccine